Investors seeking to balance the need for passive income and desire for growth to combat inflation should focus on quality ...

Altria (NYSE:MO) is set to report fourth quarter earnings on Thursday, and investors will focus on the tobacco giant’s ...

Valentine’s Day is just around the corner and finding the perfect restaurant to take the one you love can always be ...

Here are five well-known but undervalued dividend-paying stocks that look like outstanding ideas for investors to buy in 2025 ...

Following an extensive scientific review, the US Food and Drug Administration has authorized the marketing of 20 ZYN nicotine pouch products.

Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid ...

ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...

Shares of Philip Morris ( NYSE: PM) snapped six straight sessions of gains, as the stock closed 0.74% down at $122.89 on ...

The FDA has given marketing authorization to Zyn nicotine pouches. That doesn't necessarily mean they're safe to use, ...

This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.